MOSAIQ Oncology Information System
Class II · Ongoing
Software may fail to load adapted baseline shift plan during treatment delivery when a communication error occurs.
Advertisement
Advertisement
Affected lots / codes — check yours against thisSoftware Version: MOSAIQ 3.2/UDI: 07340201500071
- Recalling firm
- Elekta, Inc., Atlanta, GA
- Classification
- Class II (temporary or reversible harm possible)
- Status
- Ongoing
- Quantity
- 12 programs
- Distribution
- Worldwide - US Nationwide distribution in the states of WI, FL, LA, NY, NY, NJ, KS, FL, IA, NM, TX and the countries of Bahrain, Belgium, Canada, China, Denmark, France, Germany, Hong Kong, India, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, Pakistan, Panama, Poland, Spain, Sweden…
- Recall initiated
- May 21, 2026
- Classified
- June 11, 2026
- Initiation
- Voluntary: Firm initiated
Advertisement
Official source. This record is published by the U.S. FDA through the openFDA
enforcement database. View the unmodified government record:
https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-2406-2026%22
https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-2406-2026%22
Advertisement
Important. Recalls target specific lots and codes — compare the affected lots
above against your own product. This page reproduces public FDA data for readability;
EveryRecall is independent and not affiliated with the FDA.
Check this brand across all 8 databases →